EPISODE · Oct 30, 2024 · 7 MIN
Posterior Segment Company Updates
from Eyewire News: The Podcast · host Eyewire News
Several companies with product candidates in the posterior segment provide updates; Ocuphire acquires an ophthalmic gene therapy company; and Astellas provides an update on its regulatory plans for GA drug avacincaptad pegol. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Posterior Segment Company Updates
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m